Anogenital dermatitis in patients referred for patch testing: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004

Erin M. Warshaw, Laura M. Furda, Howard I. Maibach, Robert L. Rietschel, Joseph F. Fowler, Donald V. Belsito, Kathryn A. Zug, Vincent A. DeLeo, James G. Marks, C. G Toby Mathias, Melanie D. Pratt, Denis Sasseville, Frances Storrs, James S. Taylor

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objectives: To characterize patients with anogenital dermatitis referred for patch testing by the North American Contact Dermatitis Group, to identify common allergens, and to explore sex associations. Design: Retrospective, cross-sectional analysis of the North American Contact Dermatitis Group database, 1994-2004. Patients: Five hundred seventy-five patients with anogenital signs or symptoms were referred for patch testing; 347 had anogenital disease only. Main Outcome Measure: Currently relevant allergic patch test reaction in patients with anogenital signs or symptoms. Results: Sex percentages and mean age were not significantly different in patients with anogenital involvement only compared with those without anogenital involvement. In patients with anogenital involvement only, a final diagnosis of "other dermatoses" was statistically significantly more common in female patients compared with male patients (n=347; relative risk, 1.99; 95% confidence interval, 1.37-2.91), but the diagnosis of allergic contact dermatitis was not associated with sex. Specific allergens that were statistically significantly more common in patients with anogenital involvement included cinnamal (or cinnamic aldehyde), dibucaine, benzocaine, hydrocortisone-17-butyrate, and budesonide (all P

Original languageEnglish (US)
Pages (from-to)749-755
Number of pages7
JournalArchives of Dermatology
Volume144
Issue number6
DOIs
StatePublished - Jun 2008

Fingerprint

Contact Dermatitis
Dermatitis
Cross-Sectional Studies
Allergens
Signs and Symptoms
Dibucaine
Benzocaine
Budesonide
Allergic Contact Dermatitis
Patch Tests
Skin Diseases
Outcome Assessment (Health Care)
Databases
Confidence Intervals

ASJC Scopus subject areas

  • Dermatology

Cite this

Anogenital dermatitis in patients referred for patch testing : Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004. / Warshaw, Erin M.; Furda, Laura M.; Maibach, Howard I.; Rietschel, Robert L.; Fowler, Joseph F.; Belsito, Donald V.; Zug, Kathryn A.; DeLeo, Vincent A.; Marks, James G.; Mathias, C. G Toby; Pratt, Melanie D.; Sasseville, Denis; Storrs, Frances; Taylor, James S.

In: Archives of Dermatology, Vol. 144, No. 6, 06.2008, p. 749-755.

Research output: Contribution to journalArticle

Warshaw, EM, Furda, LM, Maibach, HI, Rietschel, RL, Fowler, JF, Belsito, DV, Zug, KA, DeLeo, VA, Marks, JG, Mathias, CGT, Pratt, MD, Sasseville, D, Storrs, F & Taylor, JS 2008, 'Anogenital dermatitis in patients referred for patch testing: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004', Archives of Dermatology, vol. 144, no. 6, pp. 749-755. https://doi.org/10.1001/archderm.144.6.749
Warshaw, Erin M. ; Furda, Laura M. ; Maibach, Howard I. ; Rietschel, Robert L. ; Fowler, Joseph F. ; Belsito, Donald V. ; Zug, Kathryn A. ; DeLeo, Vincent A. ; Marks, James G. ; Mathias, C. G Toby ; Pratt, Melanie D. ; Sasseville, Denis ; Storrs, Frances ; Taylor, James S. / Anogenital dermatitis in patients referred for patch testing : Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004. In: Archives of Dermatology. 2008 ; Vol. 144, No. 6. pp. 749-755.
@article{56e811af5c214864977bfa698862b72d,
title = "Anogenital dermatitis in patients referred for patch testing: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004",
abstract = "Objectives: To characterize patients with anogenital dermatitis referred for patch testing by the North American Contact Dermatitis Group, to identify common allergens, and to explore sex associations. Design: Retrospective, cross-sectional analysis of the North American Contact Dermatitis Group database, 1994-2004. Patients: Five hundred seventy-five patients with anogenital signs or symptoms were referred for patch testing; 347 had anogenital disease only. Main Outcome Measure: Currently relevant allergic patch test reaction in patients with anogenital signs or symptoms. Results: Sex percentages and mean age were not significantly different in patients with anogenital involvement only compared with those without anogenital involvement. In patients with anogenital involvement only, a final diagnosis of {"}other dermatoses{"} was statistically significantly more common in female patients compared with male patients (n=347; relative risk, 1.99; 95{\%} confidence interval, 1.37-2.91), but the diagnosis of allergic contact dermatitis was not associated with sex. Specific allergens that were statistically significantly more common in patients with anogenital involvement included cinnamal (or cinnamic aldehyde), dibucaine, benzocaine, hydrocortisone-17-butyrate, and budesonide (all P",
author = "Warshaw, {Erin M.} and Furda, {Laura M.} and Maibach, {Howard I.} and Rietschel, {Robert L.} and Fowler, {Joseph F.} and Belsito, {Donald V.} and Zug, {Kathryn A.} and DeLeo, {Vincent A.} and Marks, {James G.} and Mathias, {C. G Toby} and Pratt, {Melanie D.} and Denis Sasseville and Frances Storrs and Taylor, {James S.}",
year = "2008",
month = "6",
doi = "10.1001/archderm.144.6.749",
language = "English (US)",
volume = "144",
pages = "749--755",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Anogenital dermatitis in patients referred for patch testing

T2 - Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004

AU - Warshaw, Erin M.

AU - Furda, Laura M.

AU - Maibach, Howard I.

AU - Rietschel, Robert L.

AU - Fowler, Joseph F.

AU - Belsito, Donald V.

AU - Zug, Kathryn A.

AU - DeLeo, Vincent A.

AU - Marks, James G.

AU - Mathias, C. G Toby

AU - Pratt, Melanie D.

AU - Sasseville, Denis

AU - Storrs, Frances

AU - Taylor, James S.

PY - 2008/6

Y1 - 2008/6

N2 - Objectives: To characterize patients with anogenital dermatitis referred for patch testing by the North American Contact Dermatitis Group, to identify common allergens, and to explore sex associations. Design: Retrospective, cross-sectional analysis of the North American Contact Dermatitis Group database, 1994-2004. Patients: Five hundred seventy-five patients with anogenital signs or symptoms were referred for patch testing; 347 had anogenital disease only. Main Outcome Measure: Currently relevant allergic patch test reaction in patients with anogenital signs or symptoms. Results: Sex percentages and mean age were not significantly different in patients with anogenital involvement only compared with those without anogenital involvement. In patients with anogenital involvement only, a final diagnosis of "other dermatoses" was statistically significantly more common in female patients compared with male patients (n=347; relative risk, 1.99; 95% confidence interval, 1.37-2.91), but the diagnosis of allergic contact dermatitis was not associated with sex. Specific allergens that were statistically significantly more common in patients with anogenital involvement included cinnamal (or cinnamic aldehyde), dibucaine, benzocaine, hydrocortisone-17-butyrate, and budesonide (all P

AB - Objectives: To characterize patients with anogenital dermatitis referred for patch testing by the North American Contact Dermatitis Group, to identify common allergens, and to explore sex associations. Design: Retrospective, cross-sectional analysis of the North American Contact Dermatitis Group database, 1994-2004. Patients: Five hundred seventy-five patients with anogenital signs or symptoms were referred for patch testing; 347 had anogenital disease only. Main Outcome Measure: Currently relevant allergic patch test reaction in patients with anogenital signs or symptoms. Results: Sex percentages and mean age were not significantly different in patients with anogenital involvement only compared with those without anogenital involvement. In patients with anogenital involvement only, a final diagnosis of "other dermatoses" was statistically significantly more common in female patients compared with male patients (n=347; relative risk, 1.99; 95% confidence interval, 1.37-2.91), but the diagnosis of allergic contact dermatitis was not associated with sex. Specific allergens that were statistically significantly more common in patients with anogenital involvement included cinnamal (or cinnamic aldehyde), dibucaine, benzocaine, hydrocortisone-17-butyrate, and budesonide (all P

UR - http://www.scopus.com/inward/record.url?scp=45349104943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45349104943&partnerID=8YFLogxK

U2 - 10.1001/archderm.144.6.749

DO - 10.1001/archderm.144.6.749

M3 - Article

C2 - 18559763

AN - SCOPUS:45349104943

VL - 144

SP - 749

EP - 755

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 6

ER -